IBER.U
Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant
IBER.U
IBER.U
Delisted
IBER.U was delisted on the 1st of March, 2023.
18 hedge funds and large institutions have $22.5M invested in Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
18
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$103K | |
| 2 | +$17.6K | |
| 3 | +$5.82K | |
| 4 |
CS
Clear Street
New York
|
+$3K |
Top Sellers
| 1 | -$147K | |
| 2 | -$103K | |
| 3 | -$53.1K | |
| 4 |
SMA
Sage Mountain Advisors
Atlanta,
Georgia
|
-$20.9K |
| 5 |
CCM
Condor Capital Management
Martinsville,
New Jersey
|
-$3.45K |